Skip to main content

Table 2 Patient characteristics of the randomized controlled trials

From: High-flow nasal cannula oxygen versus conventional oxygen therapy for acute respiratory failure due to COVID-19: a systematic review and meta-analysis

Study

Group (N)

Age, y

Sex (male, n, %)

BMI > xx kg/m2

Severity score (admission)

Baseline oxygenation level

Respiratory rate, /min

FiO2

Flow rate (L/min)

Proning (n, %)

Cortico-steroids (n, %)

Intubation (n / N, %)

Mortality (n / N, %)

LOS in ICU, d

LOS in hospital, d

Bouadma, 2022

HFNC (115)

65 ± 10

91 (79)

30 ± 5 

>30 kg/m2 46 (40%)

SOFA

3 ± 1

SpO2

95 ± 4

24 ± 6

0.79 ± 0.41

50 ± 15

NA

115 (100)

38/115 (33)

47/115 (41)

9.5 ± 7.1

16.6 ± 10.6

COT (109)

66 ± 9

84 (77)

29 ± 4 

> 30 kg/m2 44 (40%)

SOFA

3 ± 1

SpO2

94 ± 3

25 ± 7

NA

15 ± 0

NA

109 (100)

31/109 (28)

41/109 (38)

10.8 ± 11.7

17.6 ± 10.7

Crimi, 2022

HFNC (181)

59 ± 15

119 (66)

29 ± 4 

≥ 30 kg/m2 60 (33%)

NA

PaO2:FiO2

271 ± 21

22 ± 3

0.45 ± 0.16

52 ± 9

68 (38)

180 (99)

4/181 (2)

14/181 (8)

10.1

 ± 8.5

13.6 ± 8.5

COT (181)

59 ± 15

112 (62)

28 ± 5 

≥ 30 kg/m2 58 (32%)

NA

PaO2:FiO2

276 ± 20

22 ± 4

0.42 ± 0.15 Conversion method not given

NA

70 (39)

180 (99)

7/181 (4)

13/181 (7)

12.1 ± 9.3

16.1 ± 15.1

Frat, 2022

HFNC (357)

61 ± 12

250 (70)

29 ± 5

SAPS II

31 ± 10

PaO2:FiO2

128 ± 31

28 ± 6

0.58 ± 0.08

51 ± 10

98 (28)

338 (95)

160/357 (45)

36/357 (10)

12.8 ± 14.0

18.4 ± 11.5

COT (354)

61 ± 12

247 (70)

29 ± 6

SAPS II

29 ± 13

PaO2:FiO2

132 ± 31

29 ± 6

0.58 ± 0.07

13 ± 3

83 (24)

335 (95)

186/354 (52)

40/354 (11)

13.9 ± 15.5

19.7 ± 14.3

Nazir, 2022

HFNC (60)

54 ± 12

28 (47)

NA

NA

PaO2:FiO2

207 ± 5

28 ± 1

NA

NA

48 (80)

56 (93)

2/60 (3)

3/60 (5)

NA

NA

COT (60)

57 ± 3

32 (53)

NA

NA

PaO2:FiO2

208 ± 4

28 ± 1

NA

NA

45 (75)

58 (97)

8/60 (13)

5/60 (8)

NA

NA

Ospina-Tascón, 2021

HFNC (99)

59 ± 14

71 (72)

29 ± 4

SOFA

10 ± 3

PaO2:FiO2

112 ± 38

29 ± 4

0.63 ± 0.09

60 ± 0

74 (75)

4 (4)

34/99 (34)

8/99 (8)

10.2 ± 8.5

15.8 ± 10.5

COT (100)

57 ± 13

63 (63)

30 ± 5

SOFA

10 ± 3

PaO2:FiO2

117 ± 47

29 ± 4

0.85 ± 0.00

15 ± 0

64 (64)

10 (10)

51/100 (51)

16/100 (16)

15.3 ± 18.6

18.7 ± 15.1

Perkins, 2022

HFNC (418)

58 ± 13

272 (65)

 > 35 kg/m2 81 (19%)

NA

PaO2:FiO2

136 ± 81

25 ± 7

0.60 ± 0.26

52 ± 2

243/341 (71%)

NA

170/415 (41)

78/416 (19)

10.5 ± 15.6

18.3 ± 20.0

COT (475)

58 ± 13

312 (66)

 > 35 kg/m2 75 (16%)

NA

PaO2:FiO2

124 ± 53

24 ± 6

0.60 ± 0.26

NA

252/374 (67%)

NA

153/368 (42)

74/370 (20)

9.6 ± 14.1

17.1 ± 18.0

  1. Categorical data are expressed as number of patients (percentage of total group size). Continuous data are expressed as mean ± standard deviation
  2. BMI body mass index; COT conventional oxygen therapy; FiO2 fraction of inspired oxygen; HFNC high-flow nasal cannula therapy; NA not available data; PaO2 arterial partial pressure of oxygen; SpO2 oxygen saturation as measured by pulse oximetry